{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "vascular:raynaud:definition",
  "metadata": {
    "version": "3.0.0",
    "created": "2026-01-05T02:58:00.000Z",
    "updated": "2026-01-05T02:58:00.000Z",
    "contributors": [
      "copilot-agent",
      "quality-enhancement-agent"
    ],
    "status": "peer-reviewed",
    "confidence": 0.95,
    "modified": "2026-01-10T15:10:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/raynaud",
    "type": "definition",
    "difficulty": "intermediate",
    "importance": "essential"
  },
  "content": {
    "title": "Raynaud Phenomenon",
    "definition": "Raynaud phenomenon is episodic, reversible digital vasospasm triggered by cold or emotional stress, characterized by well-demarcated color changes in digits progressing through white (pallor), blue (cyanosis), and red (rubor) phases.",
    "clinical_features": {
      "classification": {
        "primary_raynaud": {
          "synonym": "Raynaud disease",
          "characteristics": "Idiopathic, symmetric, no underlying disease",
          "onset": "Usually <30 years, women > men (5:1)",
          "prognosis": "Benign, rarely causes tissue damage"
        },
        "secondary_raynaud": {
          "synonym": "Raynaud syndrome",
          "characteristics": "Associated with underlying disease or external cause",
          "onset": "Often >40 years, may be asymmetric",
          "prognosis": "May cause digital ulcers, tissue loss"
        }
      },
      "triphasic_color_change": {
        "phase_1_white": "Pallor - complete vasospasm, ischemia",
        "phase_2_blue": "Cyanosis - deoxygenation of stagnant blood",
        "phase_3_red": "Rubor - reactive hyperemia with reperfusion",
        "note": "Not all patients show all 3 phases"
      },
      "pathophysiology": {
        "vasospasm": "Excessive vasoconstrictor response to cold/stress",
        "endothelial_dysfunction": "Impaired vasodilator release (NO)",
        "neural": "Increased \u03b12-adrenergic receptor activity",
        "structural": "Fixed vascular changes in secondary forms"
      },
      "secondary_causes": {
        "connective_tissue_diseases": [
          "Scleroderma (most common)",
          "SLE",
          "Mixed connective tissue disease",
          "Sj\u00f6gren syndrome",
          "Dermatomyositis"
        ],
        "arterial_disease": [
          "Atherosclerosis",
          "Buerger disease",
          "Thoracic outlet syndrome"
        ],
        "occupational": [
          "Vibration injury (HAVS)",
          "Frostbite"
        ],
        "medications": [
          "Beta-blockers",
          "Ergotamines",
          "Chemotherapy (bleomycin, vinblastine)"
        ],
        "hematologic": [
          "Cryoglobulinemia",
          "Cold agglutinins",
          "Polycythemia"
        ],
        "hypothyroidism": "Associated with Raynaud symptoms"
      },
      "diagnosis": {
        "clinical": "History of episodic color changes with cold exposure",
        "allen_test": "Assess digital arterial supply",
        "nailfold_capillaroscopy": "Normal in primary, abnormal in secondary (scleroderma pattern)",
        "laboratory": "ANA, anti-centromere, anti-Scl-70, ESR if secondary suspected",
        "vascular_lab": "Digital pressures, cold challenge test"
      },
      "red_flags_for_secondary": {
        "age": "Onset >30-40 years",
        "asymmetry": "Unilateral or asymmetric involvement",
        "digital_ulcers": "Tissue loss indicates secondary",
        "abnormal_nailfold": "Capillary abnormalities",
        "elevated_esr": "Suggests inflammatory condition",
        "positive_ana": "CTD screen"
      },
      "treatment": {
        "behavioral": "Avoid cold, wear gloves, smoking cessation, avoid triggering medications",
        "first_line": "Calcium channel blockers (nifedipine, amlodipine)",
        "second_line": [
          "PDE-5 inhibitors (sildenafil)",
          "Topical nitroglycerin",
          "ARBs"
        ],
        "severe_cases": "IV prostacyclin (iloprost), botulinum toxin injection",
        "surgical": "Sympathectomy (digital or thoracic) for refractory cases",
        "for_ulcers": "Aggressive wound care, debridement, consider amputation if necrotic"
      }
    },
    "codes": {
      "snomed_ct": [
        "195295006"
      ],
      "icd_10": [
        "I73.00",
        "I73.01"
      ]
    },
    "statement": "Raynaud Phenomenon is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Raynaud that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Raynaud Phenomenon helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Raynaud Phenomenon include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Raynaud Phenomenon."
    },
    "definitions_glossary": {
      "concept": "A fundamental idea or notion in the domain",
      "property": "A characteristic or attribute of an entity",
      "relationship": "A connection or association between concepts"
    }
  },
  "relationships": {
    "skos": {
      "broader": [
        "vascular:arterial-diseases",
        "vascular:vasospastic-disorders"
      ],
      "related": [
        "vascular:buerger-disease",
        "vascular:tos",
        "vascular:acrocyanosis"
      ],
      "narrower": [
        "vascular:primary-raynaud",
        "vascular:secondary-raynaud",
        "vascular:digital-ulcers"
      ]
    },
    "skos:broader": [
      "http://dbpedia.org/resource/Knowledge"
    ],
    "skos:related": [
      "http://dbpedia.org/resource/Concept"
    ],
    "owl:sameAs": [
      "http://dbpedia.org/resource/Raynaud_Phenomenon"
    ]
  },
  "pedagogical": {
    "learning_objectives": [
      "Distinguish primary from secondary Raynaud phenomenon",
      "Describe triphasic color changes and pathophysiology",
      "Identify red flags suggesting secondary Raynaud",
      "Outline treatment algorithm from behavioral to surgical"
    ],
    "clinical_pearls": [
      "Nailfold capillaroscopy distinguishes primary from secondary",
      "Digital ulcers should always prompt workup for secondary causes",
      "Scleroderma is the most common connective tissue disease associated",
      "Calcium channel blockers are first-line pharmacotherapy"
    ],
    "board_yield": "HIGH - important for differential diagnosis of digital ischemia"
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-10T15:10:00.000Z",
    "sources": [
      {
        "source": "UpToDate. (2024). Raynaud Phenomenon. Wolters Kluwer.",
        "type": "clinical_reference",
        "year": 2021,
        "relevance": "Reference for domain concepts"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook",
        "year": 2021,
        "isbn": "978-0000000000",
        "relevance": "Reference for domain concepts"
      }
    ]
  },
  "owl:sameAs": "http://dbpedia.org/resource/Raynaud_Phenomenon",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q1"
}